AR and prostate cancer: To validate the findings in a hormone‐native setting, we generated tumor xenografts with VCaP, a prostate cancer cell line that expresses androgen receptor (AR) and grows in an androgen‐sensitive manner (Kim, Watson, et al., 2018).